Advicenne Inc. is the US arm of Advicenne S.A., a Publicly traded French pharmaceutical Company developing Pathbreaking treatments
for rare diseases. Our focus in the US is the clinical program for ADV7103. ADV7103 is an investigational drug designed to treat distal renal tubular acidosis (dRTA) in patients of all ages. ADV7103 is also being developed for the treatment of a second indication, cystinuria, an inherited renal tubulopathy.
Company Details
- Address
- Greater Philadelphia, Pa 19003, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://advicenne.com/
- HQ
- Greater Philadelphia, PA
Advicenne Inc. Questions
Advicenne Inc.'s website is https://advicenne.com/
Advicenne Inc.'s LinkedIn profile is https://www.linkedin.com/company/advicenne-inc
Advicenne Inc.'s industry is
Pharmaceutical Manufacturing
Advicenne Inc.'s top competitors are
Alliance Foundation Trials, Llc,
Rqfocus,
Alfasigma,
Guard Therapeutics,
Arthesys,
Apellis Pharmaceuticals,
Aids Malignancy Consortium (Amc),
Averoa,
Advicenne,
Slope.
Advicenne Inc.'s categories are Pharmaceutical Manufacturing
